Preparation method and application of thermosensitive collagen exosome composite hydrogel preparation for endometrial repair

Through the thermosensitive collagen exosome compound hydrogel preparation, the problems of low retention rate of stem cell transplantation and short exosome retention time are solved, effective repair and regeneration of the endometrium is achieved, recurrence of adhesions and improvement of pregnancy Rate.

CN115054678BActive Publication Date: 2024-12-03KANGKNE BIOMEDICAL (SHENZHEN) CO LTD
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202210817132.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-07-12
Publication Date
2024-12-03
Estimated Expiration
2042-07-12

AI Technical Summary

Technical Problem

In the treatment of endometrial injury, especially in uterine adhesions and infertility problems, the retention rate of stem cell transplantation is low and the survival rate is low, and the retention time of direct injection of exosomes is short, making it difficult to achieve effective repair and regeneration.

Method used

Using the temperature-sensitive collagen exosome composite hydrogel preparation, the collagen solution prepared at 0-10°C and cured at physiological temperature and mixed with the exosome solution to form an injectable liquid mixture to prolong the exocrine The biological activity and retention time of the body promote endometrial repair.

Benefits of technology

It achieves long-term release of exosomes, improves the repair effect of the endometrium, reduces adhesion recurrence, enhances endometrial regeneration and microvascular formation, improves pregnancy rate, and avoids the need for multiple surgeries.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115054678B_ABST
    Figure CN115054678B_ABST
Patent Text Reader

Abstract

The present invention relates to a preparation method and application of a thermosensitive collagen exosome composite hydrogel preparation for endometrial repair. The composite hydrogel is a fluid, injectable liquid mixture at a temperature of 0-10°C and can solidify at a physiological temperature. The preparation steps are as follows: S1, preparing a collagen solution and storing it under low temperature conditions for standby use; S2, culturing and amplifying mesenchymal stem cells, and collecting stem cell culture supernatant for standby use under low temperature conditions; S3, extracting exosomes by multiple centrifugation methods to prepare an exosome solution; S4, preparing a collagen exosome composite hydrogel preparation and storing it under low temperature conditions, and also discloses the application of the preparation. The preparation of the invention can solve the problem of short retention time and low retention rate of directly using exosomes, realize long-term sustained release of exosomes, effectively promote the regeneration and repair of damaged endometrium, and solve the problems of infertility and recurrent miscarriage caused by endometrial damage.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a therapeutic agent for endometrium, in particular to a preparation method and application of a thermosensitive collagen exosome composite hydrogel preparation for endometrium repair. Background Art

[0002] Endometrial injury is a very common tissue lesion in obstetrics and gynecology, which is generally caused by surgical injury or inflammation, such as curettage, abortion, endometrial inflammation, etc. Endometrial injury is common in obstetric and gynecological diseases such as intrauterine adhesions and thin uterus. Endometrial injury can lead to secondary amenorrhea, infertility, habitual abortion, etc. According to literature reports, the incidence of intrauterine adhesions caused by artificial abortion and curettage is as high as 25%-30%. And the probability of postoperative adhesion recurrence is very high. At present, the standard treatment for intrauterine adhesions at home and abroad is hysteroscopic adhesion separation combined with postoperative artificial cycle to promote endometrial regeneration. This treatment method can effectively restore the uterine cavity morphology and relieve clinical symptoms, but it has limited effect on patients with severe adhesions, and after surgery, adhesions will recur due to endometrial regeneration disorders. Therefore, the current treatment of infertility and recurrent abortion caused by severe intrauterine adhesions and thin endometrium is a very big challenge. The key to solving the above problems is to effectively prevent adhesions while promoting the regeneration and repair of damaged endometrium.

[0003] In recent years, with the development of cell therapy technology, mesenchymal stem cells have been widely studied for the regeneration and repair of the endometrium. However, a number of prospective clinical studies have found that direct transplantation of stem cells has poor long-term clinical effects, mainly due to its low retention rate and survival rate after transplantation. In addition, direct transplantation of stem cells may have problems such as tumorigenicity, tumorigenicity, and microvascular embolism, which greatly limits its rapid clinical promotion and application. However, endometrial regeneration is a slow and long process. The retention time and efficiency of exosomes directly injected into the uterine cavity are extremely low, only a few minutes to a few hours, and it is difficult to achieve an effective repair-promoting effect. Therefore, it is necessary to adopt a certain method to achieve the continuous and effective release of exosomes in the uterine cavity and prolong their biological activity. Summary of the invention

[0004] In view of the existing deficiencies, the present invention provides a preparation method and application of a thermosensitive collagen exosome composite hydrogel preparation for endometrial repair.

[0005] The technical solution adopted by the present invention to solve the technical problem is: a method for preparing a thermosensitive collagen exosome composite hydrogel preparation for endometrial repair, wherein the composite hydrogel is a fluid, injectable liquid mixture at a temperature of 0-10°C and a hydrogel that can solidify at a physiological temperature. The liquid mixture is prepared within 24 hours before use, and the preparation steps are as follows:

[0006] S1, preparing a collagen solution and storing it at 0-10°C for later use; the collagen solution is prepared by the following steps:

[0007] S1a, collect collagen-containing tissues from the animal body;

[0008] S1b, defatting, enzymolysis, salting out, and dialyzing the collected animal body tissues in sequence, and then dissolving them under acidic conditions, and diluting them with pure water to form a solution with a weight percentage concentration of 1%-4%;

[0009] S1c, adjusting the pH value of the solution prepared in S1b to a pH value of 6.5-7.8;

[0010] S2, culturing and amplifying mesenchymal stem cells, collecting the supernatant solution of the culture medium after the culturing and amplification are completed, and storing it at 0-10° C. for future use; the culturing and amplification of the mesenchymal stem cells uses mesenchymal stem cells of passages P3-P8, and the culturing and amplification steps are as follows:

[0011] S2a, the selected mesenchymal stem cells were cultured at 1-2*10 6 The cells were inoculated at a density of 100 μg / mL in a cell culture flask, and then DMEM / F12 complete medium was added thereto. The cells were cultured at 37°C in a 5% CO2 incubator, and the medium was changed periodically until the cell confluence reached 70-80%, and then the medium was changed to serum-free medium and cultured for 48 h.

[0012] S2b, collecting the supernatant solution of the culture medium and storing it at a temperature of 0-10°C for later use;

[0013] S3, extracting exosomes from the collected supernatant solution by multiple centrifugation separation at a temperature of 0-10°C to prepare an exosome solution with a certain concentration, and storing it at a temperature of -80°C for standby use, wherein the exosomes in the exosome solution have a certain particle size and can express markers; the specific steps are as follows:

[0014] S3a, performing a primary centrifugation on the collected supernatant solution of the culture medium at a temperature of 0-10°C, at 300 g, for 10 min, and collecting the supernatant of the primary centrifugation;

[0015] S3b, subjecting the supernatant of the first centrifugation to a second centrifugation at 2000 g for 10 min, and collecting the supernatant of the second centrifugation;

[0016] S3c, the supernatant of the second centrifugation is subjected to a third centrifugation at 10,000 g for 30 min, the supernatant of the third centrifugation is discarded, and the bottom precipitate of the third centrifugation is collected;

[0017] S3d, diluting the bottom precipitate of the third centrifugation with PBS and centrifuging for the fourth time, the centrifugation condition is 100000g, the centrifugation time is 70min, the supernatant of the fourth centrifugation is discarded, and the bottom precipitate of the fourth centrifugation is collected;

[0018] S3e, resuspending the bottom precipitate from the fourth centrifugation with PBS to form a resuspension, filtering the resuspension and collecting the filtrate to form an exosome solution, which is stored at -80°C;

[0019] S4, mixing the collagen solution and the exosome solution in a volume ratio of 1-10:1 to prepare a collagen-exosome composite hydrogel preparation, and storing it at 0-10°C; before mixing the collagen solution and the exosome solution, there is also a step of diluting the exosome solution, and the exosome solution is diluted to a concentration of 5-20 ug / ml.

[0020] Preferably, the mesenchymal stem cells are cultured and expanded using mesenchymal stem cells of passages P3-P8, and the culture and expansion steps are as follows:

[0021] As an advantage, it also includes the steps of:

[0022] S3f, identify the isolated exosomes, and identify the surface markers CD63 and CD81 by western blot and flow cytometry; detect the size of exosomes in dry and wet states by transmission electron microscopy and nanoparticle tracking analysis, and the particle size should be 30-150nm;

[0023] S3g, quantitatively characterize the isolated exosomes and determine whether their concentration reaches the specified concentration by the BCA method.

[0024] Preferably, the exosome solution is centrifuged at 4°C and stored at -80°C, and the collagen solution and exosome composite hydrogel preparation are both stored at 4°C.

[0025] Preferably, the exosomes are extracted from the supernatant solution of the mesenchymal stem cell culture medium by ultracentrifugation.

[0026] Preferably, the mesenchymal stem cells are one or more of umbilical cord, placenta, bone marrow, fat, endometrium, and amniotic membrane stem cells.

[0027] A use of a thermosensitive collagen exosome composite hydrogel preparation prepared as described in any of the above items in the preparation of a drug for endometrial repair, which is injected into the uterus within 24 hours after preparation.

[0028] The beneficial effects of the present invention are as follows: the invention constructs collagen and exosomes into a temperature-sensitive responsive gel system, realizes injectability during application and solidification after injection, improves the convenience of clinical operation, shortens the operation time, and at the same time, the curable feature improves the retention of the gel in the endometrial damage site, plays a role in physical isolation, and can achieve long-term release of the encapsulated exosomes, providing sufficient time for endometrial repair. After implantation, the collagen composite hydrogel preparation can remain in the endometrial damage site, promote repair while avoiding the recurrence of adhesion, and no secondary surgery is required for removal, overcoming the shortcomings of traditional treatments such as intrauterine contraceptive devices and balloon catheters that require multiple surgeries; the collagen composite hydrogel is rich in scaffolds and stem cell secretion factors, which creates a good regeneration microenvironment for endometrial regeneration, accelerates endometrial regeneration and microvascular regeneration, prevents endometrial fibrosis, and can effectively improve and prolong the uterine cavity. Direct injection of exosomes increases the residence time in the uterine cavity, achieves continuous release of exosomes, and prolongs the biological activity of exosomes. At the same time, the high biological activity of collagen provides a spatial framework for endometrial regeneration. The composite collagen exosomes can effectively promote new blood vessel formation and endometrial regeneration. Among them, collagen is produced through multiple processes, retaining the complete triple helix structure and biological activity of collagen. At the same time, the highly de-terminated characteristics make its immunogenicity very low, which improves the safety and effectiveness of use. It can provide a scaffold for endometrial regeneration, recruit the migration and proliferation of endogenous and exogenous stem cells, and promote the repair of damaged endometrium. Exosomes can overcome the problems of short retention time and low retention rate of directly injected exosomes, achieve the long-term sustained release function of exosomes, prolong its biological activity, and maximize its function. It can effectively transmit endometrial regeneration signals, promote endometrial regeneration, reduce or prevent intrauterine adhesions, restore endometrial implantation ability, and improve pregnancy rate. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 is a graph showing the release of exosomes over time in the composite hydrogel of an embodiment of the present invention;

[0030] Figure 2 This is a comparison chart of the cytotoxicity of the composite hydrogel of the embodiment of the present invention and that of the composite hydrogel without gel;

[0031] Figure 3 This is a comparison diagram of the composite hydrogel of the embodiment of the present invention on the repair of rat endometrium; DETAILED DESCRIPTION

[0032] In order to more clearly illustrate the purpose, technical solutions and advantages of the embodiments of the present invention, the present invention will be further described in conjunction with the embodiments below, and a clear and complete description will be given. Obviously, the embodiments described are partial embodiments of the present invention, rather than all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work belong to the protection scope of the present invention.

[0033] In the present invention, a method for preparing a thermosensitive collagen exosome composite hydrogel preparation for endometrial repair is provided. The composite hydrogel is a fluid, injectable liquid mixture at a temperature of 0-10°C and a hydrogel that can solidify at a physiological temperature. The liquid mixture is prepared within 24 hours before use, and the preparation steps are as follows:

[0034] S1, prepare collagen solution, and store it at 0-10℃ for future use; in this step, first collect collagen-containing tissues from animal bodies, which can be pig skin, cattle tendon, etc., and obtain preliminary collagen solution after defatting, enzymatic hydrolysis, salting out, and dialysis of the collected animal body tissues. Then, dissolve the solution under acidic conditions, and then dilute it with pure water to a concentration of 1%-4%. Finally, adjust its pH to 6.5-7.8 with an alkali solution of appropriate concentration, and store it at 4℃ for future use. Defatting can be achieved by soaking in an alkaline solution or an acid solution. Collagen provides a scaffold for cell proliferation, migration, differentiation and tissue regeneration, and making it into a gel structure can realize the carrier sustained release function.

[0035] S2, culturing and amplifying mesenchymal stem cells, collecting the supernatant of the culture medium after the culturing and amplification, and storing it at 0-10°C for later use; using mesenchymal stem cells of any generation from P3 to P8, which can be one or more of umbilical cord, placenta, fat, bone marrow, and endometrial stem cells, and adding the selected mesenchymal stem cells at a rate of 1-2*10 6 The cells were inoculated at a density of 1.50 μg / mL in a cell culture flask, and then 15-20 ml of DMEM / F12 complete medium was added thereto. The cells were cultured at 37°C in a 5% CO2 incubator, and the medium was changed every 2-3 days until the cell growth confluence reached 70-80%. The medium was then changed to serum-free medium and cultured for 48 h. The supernatant of the culture medium was then collected and stored at 0-10°C for subsequent exosome extraction.

[0036] S3, firstly, the collected supernatant solution of the culture medium is centrifuged at 4°C for the first time, at 300g for 10 min, and the supernatant of the first centrifugation is collected; then, the supernatant of the first centrifugation is centrifuged for the second time, at 2000g for 10 min, and the supernatant of the second centrifugation is collected; then, the supernatant of the second centrifugation is centrifuged for the third time, at 10000g for 30 min, the supernatant of the third centrifugation is discarded, and the bottom precipitate of the third centrifugation is collected; then, The bottom precipitate of the third centrifugation is diluted with PBS and then centrifuged for the fourth time. The centrifugation condition is 100000g, the centrifugation time is 70min, the supernatant of the fourth centrifugation is discarded, and the bottom precipitate of the fourth centrifugation is collected; finally, the bottom precipitate of the fourth centrifugation is resuspended with PBS to form a resuspension, the resuspension is filtered and the filtrate is collected to form an exosome solution, which is stored at a temperature of -20°C to -80°C, preferably at -80°C; at this time, the exosomes in the prepared exosome solution have a certain particle size and can express markers. Stem cell exosomes are disc-shaped vesicles with a diameter of 30-150nm secreted by stem cells. They are rich in active ingredients such as proteins, RNA, lipids, etc., and play an important role in intercellular signal transduction. Many studies have shown that stem cells mainly exert their effects on tissue repair and inhibition of fibrosis through paracrine effects, and exosomes are highly active ingredients in paracrine. As a medium for endometrial regeneration, exosomes can effectively transmit cell-induced regeneration signals by delivering proteins, mRNA, miRNA and other molecules to proximal or distal cells. At the same time, exosomes can avoid immune rejection reactions that may be caused by direct cell transplantation. After the exosome solution is prepared, it is next to be identified. The surface markers CD63 and CD81 are identified by western blot and flow cytometry. When it has the ability to express relevant markers, it meets the use requirements. The size of the exosomes in dry and wet states, such as particle size, number of particles, etc., is detected by transmission electron microscopy and nanoparticle tracking analysis. When the particle size is between 30-150nm, it meets the use requirements. At the same time, the isolated exosomes are quantitatively characterized, and the BCA method is used to determine whether its concentration reaches the specified concentration to see whether it meets the conditions for mixing with the collagen solution to form a thermosensitive composite hydrogel.

[0037] S4, the collagen solution and the exosome solution are mixed in a volume ratio of 1-10:1 to prepare a collagen exosome composite hydrogel preparation, and the preparation is stored at 0-10°C. Before the collagen solution and the exosome solution are mixed, the exosome solution needs to be diluted to a concentration of 5-20 ug / ml. After the exosome solution is diluted, such as diluted to 10 ug / ml, the two are mixed evenly in a corresponding volume ratio to prepare an exosome composite hydrogel, which is then stored at 4°C. The composite hydrogel prepared in this way is liquid at low temperatures (0-10°C) and can be quickly solidified at physiological temperature. The loaded exosomes can achieve a long-acting sustained release function, which can effectively promote the repair of the endometrium, promote endometrial regeneration and microvascular regeneration, and can be used to treat endometrial injury diseases such as intrauterine adhesions and thin uterus, and improve infertility, recurrent miscarriage, etc.

[0038] An application of a thermosensitive collagen exosome composite hydrogel preparation for endometrial repair, wherein the prepared exosome composite hydrogel preparation is injected into the uterus within 24 hours after preparation, and can be quickly solidified after injection, thereby improving the feasibility of clinical operation and shortening the operation time.

[0039] The specific preparation steps of the embodiment are as follows:

[0040] (1) The pig skin tissue is cleaned, and then the collagen solution is obtained through steps such as defatting, enzymatic hydrolysis, salting out, and dialysis. The collagen solution is finally dissolved in an acid solution, diluted with pure water to a concentration of 1%-4%, and finally the pH is adjusted to 6.5-7.8 with an alkali solution of appropriate concentration.

[0041] (2) Umbilical cord mesenchymal stem cells were revived and inoculated into 75 cm 2 The cells were cultured in a culture flask with DMEM / F12 complete medium. After reaching 70-80% confluence, the cells were cultured in serum-free medium for 48 h, and the supernatant was collected.

[0042] (3) The supernatant of the above culture medium was used to prepare exosomes by ultracentrifugation at 4°C. The specific steps are as follows: centrifuge at 300g for 10 minutes at 4°C to collect the supernatant; then centrifuge again at 2000g for 10 minutes to collect the supernatant, and then centrifuge at 10000g for 30 minutes to collect the supernatant; then centrifuge at 100000g for 70 minutes, carefully discard the supernatant, and collect the bottom precipitate; after diluting the bottom precipitate with PBS, centrifuge again at 100000g for 70 minutes, discard the supernatant, and resuspend with an appropriate amount of PBS; then filter with a 0.22um filter head, and the prepared exosomes are frozen at -80°C for future use;

[0043] (4) Identification of exosomes: The concentration of the above exosomes was determined by the BCA method, and the surface markers CD63 and CD81 were identified by western blot and flow cytometry. The results showed that the prepared exosomes expressed relevant markers. Subsequently, transmission electron microscopy and nanoparticle tracking analysis were used to detect the particle size and number of exosomes in dry and wet states. The results showed that the particle size was between 30-150nm, which met the size requirements of exosomes. According to the concentration measurement results, the exosomes were diluted to 10ug / ml for use;

[0044] (5) Carefully draw the collagen solution prepared in (1) above with a 1 ml syringe, with a concentration of 3% and a volume of 0.4 ml. At the same time, draw the exosome solution prepared in (3) with another 1 ml syringe. Prepare several mixed solutions with different volume ratios of collagen solution and exosome solution. Then, push the two solutions repeatedly through a three-way device several times until they are evenly mixed. Then, transfer them to a 1 ml syringe with a volume mixing ratio of 1:1, 2:1, 3:1, and 4:1. Then, place them at 4°C for use.

[0045] (6) Investigation of the thermosensitive gelation of collagen exosomes: ① After mixing the above solutions evenly, take 1 ml and add it to a vial, then heat it in a 37°C water bath. Observe the gelation from time to time, and perform corresponding operations on the mixed solutions of each volume ratio; ② Invert the vial every 1 minute to observe the flow and gelation of the solution; after about 3 minutes, it can be observed that the solutions mixed in a ratio of 2:1, 3:1, and 4:1 have good gelation, and the solution mixed in a ratio of 1:1 has partially gelled and has a slight flow;

[0046] (7) Investigation of collagen exosome release behavior: ① Weigh 0.5 ml of the above collagen exosome composite hydrogel and place it at 37°C for gelation and solidification. After gelation, add 5 ml of PBS and incubate it at 37°C with stirring at 150 rpm. Take out 0.5 ml of the solution at regular intervals (1, 3, 5, 7, 9) and measure the amount of exosomes released. The results are shown in Table 1. Figure 1 , the collagen exosome composite hydrogel exhibited cumulative sustained release behavior, proving that collagen gel can greatly increase the retention time of exosomes and achieve sustained release function;

[0047] (8) Experimental study on cytotoxicity of collagen exosome composite hydrogel: Umbilical cord mesenchymal stem cells were seeded in a 96-well plate at a density of 5000 / well. When the confluence reached more than 90%, collagen exosome composite hydrogel was added and co-cultured for 24 hours. The control without gel was used to evaluate the cytotoxicity of collagen exosomes to stem cells. The experimental results are shown in Figure 2 ,The results showed that the addition of hydrogel had no significant effect on cell activity, and there was no statistical difference compared with the control group.

[0048] (9) Study on the proliferation and migration behavior of human umbilical vein endothelial cells by collagen exosome composite hydrogel:

[0049] ① The effect of composite hydrogel on the proliferation of human umbilical vein endothelial cells was investigated by transwell (pore size 8um) co-culture system. HUVECs 4*10 4 , 200ul of composite hydrogel or exosomes were added to the upper chamber for proliferation experiment. CCK8 staining was used to determine the effect of HUVEC cell proliferation behavior in different co-culture systems. The experimental results showed that collagen exosome composite hydrogel can effectively promote the proliferation of HUVEC.

[0050] ② The active proliferation of HUVEC was evaluated by immunofluorescence staining. The cells were first fixed with 4% PFA, then permeabilized with 0.1% Triton X-100, then stained with Ki67, detected with fluorescent secondary antibody, counterstained with DAPI, and then the number of KI67-positive cells was observed by immunofluorescence. The experimental results showed that the collagen exosome composite hydrogel group showed the highest number of KI67-positive cells.

[0051] ③ 4*10 HUVECs 4 Add to the upper chamber of the transwell, then add the composite hydrogel to the lower chamber, culture at 37°C for 20 hours, then fix the cells on the upper chamber membrane, stain with 0.5% crystal violet, and then quantify under a microscope. Analyze the effect of collagen composite hydrogel on the migration behavior of HUVEC. The experimental results show that collagen exosome composite hydrogel can promote cell migration behavior.

[0052] (10) A rat model of intrauterine adhesion and uterine injury was constructed, and then 200 μl of collagen exosome composite hydrogel was injected into the injured uterus to observe the endometrial repair and pregnancy status of the rats. The results showed that the collagen exosome group showed better endometrial repair and anti-adhesion effects, as shown in Figure 3.

[0053] It should be understood that those skilled in the art may make improvements or changes based on the above description, and all such improvements and changes should fall within the scope of protection of the appended claims of the present invention.

Claims

1. A method for preparing a thermosensitive collagen exosome composite hydrogel preparation for endometrial repair, characterized in that The composite hydrogel is a fluid, injectable liquid mixture at a temperature of 0-10°C and a hydrogel that can solidify at a physiological temperature. The liquid mixture is prepared within 24 hours before use, and the preparation steps are as follows: S1, preparing a collagen solution and storing it at 0-10°C for later use; the collagen solution is prepared by the following steps: S1a, collect collagen-containing tissues from the animal body; S1b, defatting, enzymolysis, salting out, and dialyzing the collected animal body tissues in sequence, and then dissolving them under acidic conditions, and diluting them with pure water to form a solution with a weight percentage concentration of 1%-4%; S1c, adjusting the pH value of the solution prepared in S1b to a pH value of 6.5-7.8; S2, culturing and amplifying mesenchymal stem cells, collecting the supernatant solution of the culture medium after the culturing and amplification are completed, and storing it at 0-10° C. for future use; the culturing and amplification of the mesenchymal stem cells uses mesenchymal stem cells of passages P3-P8, and the culturing and amplification steps are as follows: S2a, the selected mesenchymal stem cells were cultured at 1-2*10 6 The cells were inoculated at a density of 100 μg / mL in a cell culture flask, and then DMEM / F12 complete medium was added thereto. The cells were cultured at 37°C in a 5% CO2 incubator, and the medium was changed periodically until the cell confluence reached 70-80%, and then the medium was changed to serum-free medium and cultured for 48 h. S2b, collecting the supernatant solution of the culture medium and storing it at a temperature of 0-10°C for later use; S3, extracting exosomes from the collected supernatant solution by multiple centrifugation separation at a temperature of 0-10°C to prepare an exosome solution with a certain concentration, and storing it at a temperature of -80°C for standby use, wherein the exosomes in the exosome solution have a certain particle size and can express markers; the specific steps are as follows: S3a, performing a primary centrifugation on the collected supernatant solution of the culture medium at a temperature of 0-10°C, at 300 g, for 10 min, and collecting the supernatant of the primary centrifugation; S3b, subjecting the supernatant of the first centrifugation to a second centrifugation at 2000 g for 10 min, and collecting the supernatant of the second centrifugation; S3c, the supernatant of the second centrifugation is subjected to a third centrifugation at 10,000 g for 30 min, the supernatant of the third centrifugation is discarded, and the bottom precipitate of the third centrifugation is collected; S3d, diluting the bottom precipitate of the third centrifugation with PBS and centrifuging for the fourth time, the centrifugation condition is 100000g, the centrifugation time is 70min, the supernatant of the fourth centrifugation is discarded, and the bottom precipitate of the fourth centrifugation is collected; S3e, resuspending the bottom precipitate from the fourth centrifugation with PBS to form a resuspension, filtering the resuspension and collecting the filtrate to form an exosome solution, which is stored at -80°C; S4, mixing the collagen solution and the exosome solution in a volume ratio of 1-10:1 to prepare a collagen-exosome composite hydrogel preparation, and storing it at 0-10°C; before mixing the collagen solution and the exosome solution, there is also a step of diluting the exosome solution, and the exosome solution is diluted to a concentration of 5-20 ug / ml.

2. The method for preparing the thermosensitive collagen exosome composite hydrogel preparation for endometrial repair according to claim 1, characterized in that : Also includes the steps: S3f, identify the isolated exosomes, and identify the surface markers CD63 and CD81 by western blot and flow cytometry; detect the size of exosomes in dry and wet states by transmission electron microscopy and nanoparticle tracking analysis, and the particle size should be 30-150nm; S3g, quantitatively characterize the isolated exosomes and determine whether their concentration reaches the specified concentration by the BCA method.

3. The method for preparing the thermosensitive collagen exosome composite hydrogel preparation for endometrial repair according to claim 1, characterized in that The exosome solution was centrifuged at 4°C and stored at -80°C, and the collagen solution and exosome composite hydrogel preparation were both stored at 4°C.

4. The method for preparing the thermosensitive collagen exosome composite hydrogel preparation for endometrial repair according to claim 1, characterized in that : The exosomes are extracted from the supernatant solution of mesenchymal stem cell culture medium by ultracentrifugation.

5. The method for preparing the thermosensitive collagen exosome composite hydrogel preparation for endometrial repair according to claim 1, characterized in that : The mesenchymal stem cells are one or more of umbilical cord, placenta, bone marrow, fat, endometrium, and amniotic membrane stem cells.

6. Use of the thermosensitive collagen exosome composite hydrogel preparation prepared as claimed in any one of claims 1 to 5 in the preparation of a drug for endometrial repair, characterized in that :Injected into the uterus within 24 hours of preparation.

Citation Information

Patent Citations

  • Stem cell composite collagen scaffold kit used for repairing endometrial damage, and preparation method thereof

    CN105983133A

  • Exosome-compounded collagen biological scaffold with directional releasing function as well as preparation method and application thereof

    CN107550933A

  • Polypeptide hydrogel with slow-release exosomes and preparation method and application thereof

    CN110229214A

  • Preparation method and application of temperature-sensitive hydrogel compounding PRP and collagen

    CN113577387A

  • Hydrogel loaded with stem cell exosome and recombinant collagen as well as preparation method and application of hydrogel

    CN114306098A